TVCMALL brings one-stop wholesale solution to MWC 2023
10.3.2023 15:57:00 EET | Business Wire | Press release
Recently, the 2023 Mobile World Congress (MWC) held in Barcelona turned out to be a big success. More than 88,000 attendees and 2400+ exhibitors participated in this event, including many cell phone accessories suppliers & wholesalers. As Europe's leading one-stop shop for mobile accessories and wholesale/integrated supply chain service platform, TVCMALL participated in this digital/mobile feast. TVCMALL, based in Shenzhen China, the world's electronic center, provides the esteemed customer B2B solution on mobile accessories for wholesale, sourcing, and customization. Various classic mobile cases with leather finishing, chargers with multifunctions, and Amorus portable Karaoke speaker brought by TVCMALL were highly praised by our attendees.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230307005650/en/
TVCMALL brings one-stop wholesale solution to MWC 2023 (Photo: Business Wire)
MWC is one of the world's most important telecommunications & technology shows. During the past 4 days, the aspects such as the latest trend in mobile technologies, including Intelligent equipment, 5G network, AI, and digitalization, have been introduced and shared with the world.
During the show, TVCMALL met a lot of old customers and new friends. Many of them are as follows:
- Top online mobile phone accessories retailers & distributors
- B2C platform sellers, Dropshippers
- Offline chain stores, Supermarket sellers, Telecom companies
- Gift-Customize customers (especially for government, corporate & schools and other agents)
- OEM & ODM & OBM customers
- Retail shops & Mobile phone repair shops
Many customers have cooperated with TVCMALL for over ten years since its establishment in 2008, and they have grown and developed rapidly with TVCMALL. They expressed their high recognition and gratitude to TVCMALL for providing one-stop wholesale, sourcing, customized services, and other supply chain services.
Why they choose TVCMALL as an indispensable and important long-term partner? Because TVCMALL provides complete product catalog, with more than 600,000 SKU online, and every week 6,000 new products updated. Its wholesale process, marketing support, and customer service are efficient. TVCMALL has good intention of growing together with their customers.
TVCMALL's comprehensive procurement cost is relatively low, the service consistency and stability are very strong. That’s why many customers prefer one-stop service providers like TVCMALL.
During the MWC, TVCMALL has established a bridge of contact with some excellent product suppliers and e-commerce service providers (of mobile, 3C electronic devices and accessories).
In the foreseeable future, with continuously TVCMALL brand and platform upgrading, TVCMALL will strengthen its mission, "To help entrepreneurs actualize their dreams of launching and sustaining a successful retail business", and will stick to its business operation philosophy "Together we thrive". In terms of specific strategies, TVCMALL will adhere to the following 4 directions:
- Platform Branding — Operate the TVCMALL platform as a future century-old brand
- Productization of the services — all the services of TVCMALL with the idea of Productization.
- Product Deep ploughing — Thrive to be the best.
- Localization of TVCMALL service — Go global and localization: Initiate local marketing and service team, in-depth understanding & efficient service.
TVCMALL will see you again in Barcelona 2024!
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230307005650/en/
Contact information
Shenzhen Zhenzhi Technology Co.,Ltd.
Yelly Huang
global@tvcmall.com
https://www.tvcmall.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom